Haemonetics Quick Ratio (HAE) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Haemonetics Corporation  (NYSE: HAE)

Haemonetics's Quick Ratio

HAE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Haemonetics's Cash & cash equivalent grew by 16.71 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Haemonetics's Quick Ratio to 0.87, Quick Ratio remained below Haemonetics Corporation average.

Within Medical Equipment & Supplies industry 115 other companies have achieved higher Quick Ratio than Haemonetics in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1816 to 2124.

Explain Quick Ratio?
How much Cash & cash equivalents HAE´s has?
What are HAE´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/HAE/financial-strength
https://api.csimarket.com/api/v1/companies/HAE/fundamentals
https://api.csimarket.com/api/v1/companies/HAE/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
HAE Quick Ratio (Sep 26 2026)
Q2
(Jun 27 2026)
Q1
(Mar 28 2026)
Q4
(Dec 27 2025)
Q3
(Sep 27 2025)
Q2
Y / Y Current Liabilities Change -45.13 %
Y / Y Cash & cash equivalent Change -12.05 %
Quick Ratio MRQ 0.87
HAE's Total Ranking # 2124
Seq. Current Liabilities Change 14.28 %
Seq. Cash & cash equivalent Change 16.71 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 662
Overall Market # 2124


Quick Ratio Statistics
High Average Low
5.87 1.12 0.46
(Jul 02 2011)   (Mar 31 2018)




Financial Statements
Haemonetics's Current Liabilities $ 301 Millions Visit HAE's Balance sheet
Haemonetics's Cash & cash equivalent $ 261 Millions Visit HAE's Balance sheet
Source of HAE's Sales Visit HAE's Sales by Geography


Cumulative Haemonetics's Quick Ratio

HAE's Quick Ratio for the trailling 12 Months

HAE Quick Ratio

(Sep 26 2026)
12 Months
(Jun 27 2026)
12 Months
(Mar 28 2026)
12 Months
(Dec 27 2025)
12 Months
(Sep 27 2025)
12 Months
Y / Y Current Liabilities TTM Growth -27.45 %
Y / Y Cash & cash equivalent TTM Growth -10.19 %
Quick Ratio TTM 0.79
Total Ranking TTM # 4020
Seq. Current Liabilities TTM Growth -15.15 %
Seq. Cash & cash equivalent TTM Growth -3.16 %


On the trailing twelve months basis Current Liabilities decreased faster than Haemonetics's average Cash & cash equivalent, this led to increase in in Haemonetics's Quick Ratio to 0.79, Quick Ratio remained below HAE average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Haemonetics. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3187 to 4020.

Explain Quick Ratio?
How much Cash & cash equivalents HAE´s has?
What are HAE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 205
Healthcare Sector # 900
Within the Market # 4020


trailing twelve months Quick Ratio Statistics
High Average Low
1.87 0.87 0.54
(Jun 30 2012)   (Dec 27 2025)




Companies with similar Quick Ratio in the quarter ending Sep 26 2026, within Medical Equipment & Supplies Industry Quick RatioSep 26 2026 MRQ Cash & cash equivalentSep 26 2026 MRQ Current Liabilities
Genedx Holdings Corp   2.38 $ 170.118  Millions$ 71.403  Millions
Apyx Medical Corp  2.37 $ 25.777  Millions$ 10.870  Millions
Atricure Inc   2.23 $ 187.031  Millions$ 83.972  Millions
Vivani Medical Inc   2.22 $ 14.591  Millions$ 6.585  Millions
Electromed Inc   2.19 $ 15.875  Millions$ 7.261  Millions
Inspire Medical Systems inc   1.96 $ 190.803  Millions$ 97.438  Millions
Aethlon Medical Inc   1.91 $ 6.487  Millions$ 3.403  Millions
Merit Medical Systems Inc  1.90 $ 503.551  Millions$ 265.083  Millions
Nephros Inc   1.89 $ 4.546  Millions$ 2.409  Millions
Fractyl Health Inc   1.82 $ 31.515  Millions$ 17.345  Millions
Warby Parker Inc   1.77 $ 287.914  Millions$ 162.226  Millions
Anika Therapeutics Inc   1.68 $ 44.957  Millions$ 26.725  Millions
EBR Systems, Inc.  1.63 $ 85.415  Millions$ 52.539  Millions
Beyond Air Inc   1.61 $ 17.121  Millions$ 10.632  Millions
Intuitive Surgical Inc   1.60 $ 4,042.500  Millions$ 2,533.000  Millions
Tactile Systems Technology Inc   1.58 $ 75.110  Millions$ 47.499  Millions
Edap Tms Sa  1.56 $ 56.269  Millions$ 36.070  Millions
Neuraxis Inc   1.55 $ 4.477  Millions$ 2.888  Millions
Envista Holdings Corporation  1.42 $ 1,158.800  Millions$ 816.300  Millions
Inogen Inc   1.38 $ 96.840  Millions$ 70.265  Millions
Intelligent Bio Solutions Inc   1.30 $ 5.930  Millions$ 4.578  Millions
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions
Sanara Medtech Inc   1.09 $ 17.788  Millions$ 16.282  Millions
Penumbra Inc  1.09 $ 254.282  Millions$ 233.810  Millions
Koru Medical Systems Inc   1.08 $ 7.364  Millions$ 6.792  Millions
Establishment Labs Holdings Inc   1.06 $ 75.812  Millions$ 71.611  Millions
Globus Medical Inc   1.02 $ 517.435  Millions$ 507.938  Millions
Envoy Medical Inc   0.98 $ 14.570  Millions$ 14.861  Millions

Date modified: 2026-11-08T19:25:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.